Mesoionic pesticides

US9210932B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9210932-B2
Application numberUS-201414219079-A
CountryUS
Kind codeB2
Filing dateMar 19, 2014
Priority dateAug 5, 2009
Publication dateDec 15, 2015
Grant dateDec 15, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are compounds of Formula 1, N-oxides, and salts thereof, wherein X is O or S; Y is O or S; A is O, S, NR 3e or C(R 3c )═C(R 3d ); Z is a direct bond, O, S(O) n , NR 6 , C(R 7 ) 2 O, OC(R 7 ) 2 , C(═X 1 ), C(═X 1 )E, EC(═X 1 ), C(═NOR 8 ) or C(═NN(R 6 ) 2 ); a is 1, 2 or 3; and R 1 , R 2 , R 3a -R 3e , R 4 , R 5 , R 6 , R 7 , R 8 , X 1 and E are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.

First claim

Opening claim text (preview).

What is claimed is: 1. A composition comprising a compound of Formula 1 or salt thereof, wherein X is O or S; Y is O or S; A is C(R 3c )═C(R 3d ), provided that the C(R 3c )═C(R 3d ) moiety is oriented so the carbon atom bonded to R 3d is connected directly to the pyrimidinium ring of Formula 1; Z is a direct bond, O, S(O) n , NR 6 , C(R 7 ) 2 O, OC(R 7 ) 2 , C(═X 1 ), C(═X 1 )E, EC(═X 1 ), C(═NOR 8 ) or C(═NN(R 6 ) 2 ); X 1 is O, S or NR 9 ; E is O, S or NR 9a ; R 1 is a 3- to 10-membered ring or a 7- to 11-membered ring system, each ring or ring system containing ring members selected from carbon atoms and up to 4 heteroatoms independently selected from up to 2 O, up to 2 S, and up to 4 N, wherein up to 3 carbon atom ring members are independently selected from C(═O) and C(═S) and the sulfur atom ring members are independently selected from S(═O) u (═NR 24 ) z , each ring or ring system optionally substituted with up to 5 substituents independently selected from R 14 ; R 2 is H, halogen, cyano, hydroxy, amino, nitro, OCN, SCN, CHO, C(═O)OH, C(═O)NH 2 , C(═S)NH 2 , SO 2 NH 2 , C(═O)R 18 , C(═O)OR 18 , NHR 18 , NR 18 R 19 , C(═O)NR 21 R 19 , C(═S)NR 21 R 19 , SO 2 NR 21 R 19 , OC(═O)R 21 , OC(═O)OR 18 , OC(═O)NR 21 R 19 , N(R 21 )C(═O)R 21 , N(R 21 )C(═O)OR 19 , N(R 21 )C(═O)NR 21 R 22 , OSO 2 R 18 , OSO 2 NR 21 R 22 , NR 21 SO 2 R 18 , NR 21 SO 2 NR 21 R 22 or Si(R 18 R 19 R 20 ); or C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 3 -C 10 cycloalkyl, C 4 -C 10 alkylcycloalkyl, C 4 -C 10 cycloalkylalkyl, C 6 -C 14 cycloalkylcycloalkyl, C 5 -C 10 alkylcycloalkylalkyl, C 3 -C 8 cycloalkenyl, C 1 -C 8 alkoxy, C 3 -C 8 cycloalkoxy, C 4 -C 10 cycloalkylalkoxy, C 2 -C 8 alkenyloxy, C 2 -C 8 alkynyloxy, C 1 -C 8 alkylthio, C 1 -C 8 alkylsulfinyl, C 1 -C 8 alkylsulfonyl, C 3 -C 8 cycloalkylthio, C 3 -C 8 cycloalkylsulfinyl, C 3 -C 8 cycloalkylsulfonyl, C 4 -C 10 cycloalkylalkylthio, C 4 -C 10 cycloalkylalkylsulfinyl, C 4 -C 10 cycloalkylalkylsulfonyl, C 2 -C 8 alkenylthio, C 2 -C 8 alkenylsulfinyl, C 2 -C 8 alkenylsulfonyl, C 2 -C 8 alkynylthio, C 2 -C 8 alkynylsulfinyl or C 2 -C 8 alkynylsulfonyl, each unsubstituted or substituted with at least one substituent independently selected from the group consisting of halogen, cyano, nitro, CHO, C(═O)OH, C(═O)NH 2 , C(═O)R 10 , C(═O)OR 11 , C(═O)NR 12 R 13 , OR 11 , S(O) n R 10 SO 2 NR 12 R 13 and Si(R 10 ) 3 ; or a 3- to 10-membered ring or a 7- to 11-membered ring system, each ring or ring system containing ring members selected from carbon atoms and up to 4 heteroatoms independently selected from up to 2 O, up to 2 S, and up to 4 N, wherein up to 3 carbon atom ring members are independently selected from C(═O) and C(═S) and the sulfur atom ring members are independently selected from S(═O) u (═NR 24 ) z , each ring or ring system optionally substituted with up to 5 substituents independently selected from R 15 ; R 3a , R 3b , R 3c and R 3d are independently H, halogen, cyano, hydroxy, amino, nitro, SF 5 , OCN, SCN, CHO, C(═O)OH, C(═O)NH 2 , C(═S)NH 2 , SO 2 NH 2 , C(═O)R 18 , C(═O)OR 18 , NHR 18 , NR 18 R 19 , C(═O)NR 21 R 19 , C(═S)NR 21 R 19 , SO 2 NR 21 R 19 OC(═O)R 21 , OC(═O)OR 18 , OC(═O)NR 21 R 19 , N(R 21 )C(═O)R 21 , N(R 21 )C(═O)OR 19 , N(R 21 )C(═O)NR 21 R 22 , OSO 2 R 18 , OSO 2 NR 21 R 22 , NR 21 SO 2 R 18 , NR 21 SO 2 NR 21 R 22 , Si(R 18 R 19 R 20 ) or Z 1 Q t ; or C 1 -C 8 alkyl, C 2 -C 8 alkenyl, C 2 -C 8 alkynyl, C 3 -C 10 cycloalkyl, C 4 -C 10 alkylcycloalkyl, C 4 -C 10 cycloalkylalkyl, C 6 -C 14 cycloalkylcycloalkyl, C 5 -C 10 alkylcycloalkylalkyl, C 3 -C 8 cycloalkenyl, C 1 -C 8 alkoxy, C 3 -C 8 cycloalkoxy, C 4 -C 10 cycloalkylalkoxy, C 2 -C 8 alkenyloxy, C 2 -C 8 alkynyloxy, C 1 -C 8 alkylthio, C 1 -C 8 alkylsulfinyl, C 1 -C 8 alkylsulfonyl, C 3 -C 8 cycloalkylthio, C 3 -C 8 cycloalkylsulfinyl, C 3 -C 8 cycloalkylsulfonyl, C 4 -C 10 cycloalkylalkylthio, C 4 -C 10 cycloalkylalkylsulfinyl, C 4 -C 10 cycloalkylalkylsulfonyl, C 2 -C 8 alkenylthio, C 2 -C 8 alkenylsulfinyl, C 2 -C 8 alkenylsulfonyl, C 2 -C 8 alkynylthio, C 2 -C 8 alkynylsulfinyl or C 2 -C 8 alkynylsulfonyl, each unsubstituted or substituted with at least one substituent independently selected from R 17 ; or R 3a and R 3b , or R 3b and R 3c , or R 3c and R 3d are taken together with the adjacent carbon atoms to which they are attached to form a 5- to 7-membered carbocyclic or heterocyclic ring, each ring containing ring members selected from carbon atoms and up to 3 heteroatoms independently selected from up to 2 O, up to 2 S, and up to 3 N, wherein up to 2 carbon atom ring members are independently selected from C(═O) and C(═S) and the sulfur atom ring members are independently selected from S(═O) n , each ring optionally substituted with up to 3 substituents independently selected from the group consisting of halogen, cyano, hydroxy, amino, nitro, C(═O)OH, C(═O)NH 2 , SO 2 NH 2 , C 1 -C 4 alkyl, C 1 -C 4 haloalkyl, C 2 -C 4 alkenyl, C 2 -C 4 haloalkenyl, C 2 -C 4 alkynyl, C 2 -C 4 haloalkynyl, C 3 -C 7 cycloalkyl, C 3 -C 7 halocycloalkyl, C 4 -C 8 alkylcycloalkyl, C 4 -C 8 haloalkylcycloalkyl, C 4 -C 8 cycloalkylalkyl, C 4 -C 8 halocycloalkylalkyl, C 1 -C 6 alkoxy, C 1 -C 6 haloalkoxy, C 2 -C 6 alkoxycarbonyl, C 2 -C 6 haloalkoxycarbonyl, C 2 -C 6 alkylcarbonyl and C 2 -C 6 haloalkylcarbonyl; each R 4 and R 5 is independently H, halogen, cyano, hydroxy, amino, nitro, OCN, SCN, CHO, C(═O)OH, C(═O)NH 2 , C(═S)NH 2 or SO 2 NH 2 ; or C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 8 cycloalkyl, C 4 -C 8 alkylcycloalkyl, C 4 -C 8 cycloalkylalkyl, C 6 -C 12 cycloalkylcycloalkyl, C 5 -C 8 alkylcycloalkylalkyl, C 3 -C 6 cycloalkenyl, C 1 -C 6 alkoxy, C 3 -C 6 cycloalkoxy, C 4 -C 8 cycloalkylalkoxy, C 2 -C 6 alkenyloxy or C 2 -C 6 alkynyloxy, each unsubstituted or substituted with at least one substituent independently selected from the group consisting of halogen, cyano, nitro, CHO, C(═O)OH, C(═O)NH 2 , C(═O)R 10 , C(═O)OR 11 , C(═O)NR 12 R 13 , OR 11 , S(O) n R 10 , SO 2 NR 12 R 13 and Si(R 10 ) 3 ; or R 4 and R 5 are taken together with the carbon atom to which they are attached to form a 3- to 7-membered ring containing ring members selected from carbon atoms and up to 2 heteroatoms independently selected from one O, one S, and up to 2 N, wherein up to 2 carbon atom ring members are independently selected from C(═O) and C(═S) and the sulfur atom ring member is selected from S, S(O) or S(O) 2 , said ring optionally substituted with up to 4 substituents independently selected from the group consisting of halogen, cyano and C 1 -C 4 alkyl; each R 6 is independently H; or C 1 -C 6 alkyl, C 2 -C 6 alkenyl, C 2 -C 6 alkynyl, C 3 -C 8 cycloalkyl, C 4 -C 8 alkylcycloalkyl, C 4 -C 8 cycloalkylalkyl, C 6 -C 10 cycloalkylcycloalkyl, C 5 -C 10 alkylcycloalkylalkyl, C 3 -C 6 cycloalkenyl, C 2 -C 6 alkylcarbonyl or C 2 -C 6 alkoxycarbonyl, each unsubstituted or substituted with at least one substituent independently selected from the group consisting of halogen, cyano, nitro, CHO, C(═O)OH, C(═O)NH 2 , C(═O)R 10 , C(═O)OR 11 , C(═O)NR 12 R 13 , OR 11 , S(O) n R 10 , SO 2 NR 12 R 13 and Si(R 10 ) 3 ; or two R 6 substituents are taken together with the nitrogen atom to which they are attached to form a 3- to 7-membered ring containing ring members selected from carbon atoms and up to 2 heteroatoms independently selected from one O, one S, and up to 2 N, wherein up to 2 carbon atom ring members are independently selected from C(═O) and C(═S) and the sulfur atom ring member is selected from S, S(O) or S(O) 2 , said ring optionally substituted with up to 4 substituents independently selected from the group consisting of halogen, cyano and C 1 -C 4 alkyl; each R 7

Assignees

Inventors

Classifications

  • Anthelmintics · CPC title

  • Antiparasitic agents · CPC title

  • Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title

  • Ectoparasiticides, e.g. scabicides · CPC title

  • as doubly bound oxygen atoms or as unsubstituted hydroxy radicals · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9210932B2 cover?
Disclosed are compounds of Formula 1, N-oxides, and salts thereof, wherein X is O or S; Y is O or S; A is O, S, NR 3e or C(R 3c )═C(R 3d ); Z is a direct bond, O, S(O) n , NR 6 , C(R 7 ) 2 O, OC(R 7 ) 2 , C(═X 1 ), C(═X 1 )E, EC(═X 1 ), C(═NOR 8 ) or C(═NN(R 6 ) 2 ); a is 1, 2 or 3; and R 1 , R 2 , R 3a -R 3e , R 4 , R 5 , R 6 , R 7 , R 8 , X 1 an…
Who is the assignee on this patent?
Du Pont
What technology area does this patent fall under?
Primary CPC classification A01N43/90. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Dec 15 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).